Immune thrombocytopenic purpura with subsequent development of JAK2 V617F-positive essential thrombocythemia: Case Report
Open Access
- 4 August 2021
- journal article
- Published by Peertechz Publications Private Limited in Archives of Hematology Case Reports and Reviews
- Vol. 6 (1), 018-020
- https://doi.org/10.17352/ahcrr.000033
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Immune Thrombocytopenia and JAK2V617F Positive Essential Thrombocythemia: Literature Review and Case ReportCase Reports in Hematology, 2017
- How I treat essential thrombocythemiaBlood, 2016
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaBlood, 2016
- STAT5 in Cancer and ImmunityJournal of Interferon & Cytokine Research, 2016
- Sequential occurrence of thrombotic thrombocytopenic purpura, essential thrombocythemia, and idiopathic thrombocytopenic purpura in a 42-year-old African-American woman: a case report and review of the literatureJournal of Medical Case Reports, 2012
- JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activationBritish Journal of Haematology, 2010
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- How regulatory T cells workNature Reviews Immunology, 2008
- Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective studyThe Lancet, 2005
- How I treat idiopathic thrombocytopenic purpura (ITP)Blood, 2005